Impressive Growth of Biologics to Lend Global Sterile Medical Packaging Market Significant Boost

The global market for sterile medical packaging is led by companies such as Amcor Limited, Placon, Dupont, Steripack, Wipak Group, 3M Medical Packaging, Nelipak Healthcare Packaging, Oracle Packaging, Sonoco Plastics Europe, Billerkornas AB, and Ampac Group. Transparency Market Research has observed that a number of leading packaging companies have been adopting the outsourcing model in order to expand their footprint in the sterile medical packaging market and thus generate a high ROI.

Browse the Full Report at:

http://www.transparencymarketresearch.com/sterile-medical-packaging-market.html

“Contracting with local companies helps manufacturers lower the operational cost,” the author of the study states. “Furthermore, packaging companies can benefit from better pricing by outsourcing sterile packaging.”

Some of the key strategies employed by players in the sterile medical packaging market are mergers and acquisitions, strengthening the distribution network, product expansion, and expanding into other geographical segments.

The opportunity in the global sterile medical packaging market is estimated to be worth US$26.5 bn by the end of 2016 and is projected to reach US$38.3 bn by 2024.

North America to Continue its Lead in Global Sterile Medical Packaging Market

The vials and ampoules segment is estimated to account for the leading share in the sterile medical packaging market in terms of value by 2016-end. “However, this product segment is expected to register a marginal decrease in market share by the end of the forecast period, with the pouches and bags segment likely to emerge as the dominant segment by 2024,” the lead analyst predicts. Nevertheless, the vials and ampoules segment will be one of the most attractive markets during the course of the forecast period.

Plastics are expected to be the preferred material choice for vendors in the sterile medical packaging market. By application, the pharmaceuticals and biologics segment is...